Pankit Vachhani, MD

Articles by Pankit Vachhani, MD

Novel Therapies Being Investigated in Polycythemia Vera

ByRami S. Komrokji, MD,Pankit Vachhani, MD

November 11th 2022

Before closing out their review of polycythemia vera management, expert hematologist-oncologists highlight novel therapies in the pipeline.

Selecting and Sequencing Therapy in Patients With Polycythemia Vera

ByRami S. Komrokji, MD,Pankit Vachhani, MD

November 11th 2022

Considerations for the selection of optimal therapy in patients with polycythemia vera, and how these novel agents may be sequenced in the event of disease progression.

Treatment Armamentarium for Polycythemia Vera

ByRami S. Komrokji, MD,Pankit Vachhani, MD

November 4th 2022

Centering discussion on polycythemia vera, Rami S. Komrokji, MD, and Pankit Vachhani, MD, share an in-depth review of cornerstone therapies in this setting.

Important Pathways and Biomarkers in Myeloproliferative Neoplasms

ByRami S. Komrokji, MD,Pankit Vachhani, MD

November 4th 2022

Expert hematologist-oncologists share insight on the pathways driving myeloproliferative neoplasms and biomarkers that may be targeted with novel therapy.

Myeloproliferative Neoplasms: Testing, Workup, and Diagnosis

ByRami S. Komrokji, MD,Pankit Vachhani, MD

October 28th 2022

Broad perspective on diagnosis of the myeloproliferative neoplasms via optimal workup and molecular testing.

Overview of Myeloproliferative Neoplasms

ByRami S. Komrokji, MD,Pankit Vachhani, MD

October 28th 2022

A comprehensive overview of myeloproliferative neoplasms followed by insight on the differences between essential thrombocytopenia, polycythemia vera, and myelofibrosis.